My Blog List

Monday, 23 October 2017

Global Heparin Market by Manufacturers, Regions, Type and Application, Forecast 2012-2022

Description:

This report studies the Heparin market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Heparin market by product type and applications/end industries.
The global Heparin market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Heparin.


Europe also play important roles in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX.
The major players in global market include
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen (N.V.Organon)
King-friend Biochemical Pharmaceutical
Bioiberica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma Limited
Deebio
SPL(acquired by Hepalink in 2014)


Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Heparin in these regions, from 2012 to 2022 (forecast), covering
Europe covers Germany, France, UK, Russia, Italy and Benelux;
Middle East includes Saudi Arabia, Israel, UAE and Iran;
Africa includes South Africa, Nigeria, Egypt and Algeria.
On the basis of product, the Heparin market is primarily split into
Heparin Sodium
Heparin Calcium
Others
On the basis on the end users/applications, this report covers
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter

Make an Enquiry Of report for Discount @ https://www.reporthive.com/enquiry.php?id=1096895&req_type=disc

Table of Content:

1 Heparin Market Overview1.1 Product Overview and Scope of Heparin
1.1.1 Definition of Heparin Sodium
1.1.2 Specifications of Heparin Sodium
1.2 Classification of Heparin by Product Category
1.2.1 Global Heparin Market Size Comparison by Types (2012–2022)
1.2.2 Global Heparin Market Size (Sales) Market Share by Types in 2016
1.2.3 Heparin Sodium
1.2.4 Heparin Calcium
1.2.5 Others
1.3 Global Heparin Market by Applications/End Users
1.3.1 Global Heparin Sales (Volume) and Market Share Comparison by Applications (2012–2022)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.4 Global Heparin Market by Regions
1.4.1 Global Heparin Market Size (Million USD) Comparison by Regions (2012–2022)
1.4.1 North America (USA, Canada and Mexico) Heparin Status and Prospect (2012–2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Heparin Status and Prospect (2012–2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Heparin Status and Prospect (2012–2022)
1.4.4 South America (Brazil, Argentina, Columbia) Heparin Status and Prospect (2012–2022)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Heparin Status and Prospect (2012–2022)
1.5 Global Market Size (Sales and Revenue) of Heparin (2012–2022)
1.5.1 Global Heparin Sales and Growth Rate (2012–2022)
1.5.2 Global Heparin Revenue (Value) and Growth Rate (2012–2022)

2 Global Heparin Players/Manufacturers Profiles and Sales Data2.1 Hepalink
2.1.1 Company Basic Information, Manufacturing Base and Competitors
2.1.2 Heparin Product Category, Application and Specification
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hepalink Heparin Sales (Billion Units), Revenue (Million USD), Price (USD/Billion Unit) and Gross Margin (%) (2012–2017)
2.1.4 Main Business/Business Overview
2.2 Changshan Pharm
2.2.1 Company Basic Information, Manufacturing Base and Competitors
2.2.2 Heparin Product Category, Application and Specification
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Changshan Pharm Heparin Sales (Billion Units), Revenue (Million USD), Price (USD/Billion Unit) and Gross Margin (%) (2012–2017)
2.2.4 Main Business/Business Overview
2.3 Qianhong Bio-pharma
2.3.1 Company Basic Information, Manufacturing Base and Competitors
2.3.2 Heparin Product Category, Application and Specification
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Qianhong Bio-pharma Heparin Sales (Billion Units), Revenue (Million USD), Price (USD/Billion Unit) and Gross Margin (%) (2012–2017)
2.3.4 Main Business/Business Overview
2.4 Opocrin
2.4.1 Company Basic Information, Manufacturing Base and Competitors
2.4.2 Heparin Product Category, Application and Specification
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Opocrin Heparin Sales (Billion Units), Revenue (Million USD), Price (USD/Billion Unit) and Gross Margin (%) (2012–2017)
2.4.4 Main Business/Business Overview
2.5 Pfizer
2.5.1 Company Basic Information, Manufacturing Base and Competitors
2.5.2 Heparin Product Category, Application and Specification
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Heparin Sales (Billion Units), Revenue (Million USD), Price (USD/Billion Unit) and Gross Margin (%) (2012–2017)
2.5.4 Main Business/Business Overview
2.6 Aspen (N.V.Organon)
2.6.1 Company Basic Information, Manufacturing Base and Competitors
2.6.2 Heparin Product Category, Application and Specification
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Aspen (N.V.Organon) Heparin Sales (Billion Units), Revenue (Million USD), Price (USD/Billion Unit) and Gross Margin (%) (2012–2017)
2.6.4 Main Business/Business Overview
2.7 King-friend Biochemical Pharmaceutical
2.7.1 Company Basic Information, Manufacturing Base and Competitors
2.7.2 Heparin Product Category, Application and Specification
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 King-friend Biochemical Pharmaceutical Heparin Sales (Billion Units), Revenue (Million USD), Price (USD/Billion Unit) and Gross Margin (%) (2012–2017)
2.7.4 Main Business/Business Overview
2.8 Bioibérica
2.8.1 Company Basic Information, Manufacturing Base and Competitors
2.8.2 Heparin Product Category, Application and Specification
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Heparin Sales, Revenue, Price and Gross Margin BioibĂ©rica (2012–2017)
2.8.4 Main Business/Business Overview
2.9 Dongcheng Biochemicals
2.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Heparin Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.9.3 Dongcheng Biochemicals Heparin Sales (Billion Units), Revenue (Million USD), Price (USD/Billion Unit) and Gross Margin (%) (2012–2017)
9.9.4 Main Business/Business Overview
2.10 Jiulong Biochemicals
2.10.1 Company Basic Information, Manufacturing Base and Competitors
2.10.2 Heparin Product Category, Application and Specification
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Jiulong Biochemicals Heparin Sales (Billion Units), Revenue (Million USD), Price (USD/Billion Unit) and Gross Margin (%) (2012–2017)
10.10.4 Main Business/Business Overview
2.11 Tiandong
2.12 Xinbai
2.13 Yino Pharma Limited
2.14 Deebio
2.15 SPL(acquired by Hepalink in 2014)
Read Full Table of Contents

About Report Hive Research

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Contact Us

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312–604–7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014